Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Department of Pathology and Laboratory Medicine, |
RCV001292356 | SCV001480736 | pathogenic | Polycystic kidney disease | no assertion criteria provided | clinical testing | The PKHD1 p.Glu2148X variant was not identified in the literature nor was it identified in the following databases: dbSNP, ClinVar, LOVD 3.0, or RWTH AAachen University ARPKD database. The variant was not identified in control databases: the 1000 Genomes Project, the NHLBI GO Exome Sequencing Project, the Exome Aggregation Consortium (August 8th 2016), or the Genome Aggregation Database (Feb 27, 2017). The p.Glu2148X variant leads to a premature stop codon at position 2148, which is predicted to lead to a truncated or absent protein and loss of function. Loss of function variants of the PKHD1 gene are an established mechanism of disease in autosomal recessive polycystic kidney disease and is the type of variant expected to cause the disorder. In summary, based on the above information this variant meets our laboratory’s criteria to be classified as pathogenic |